1. Home
  2. RFL vs VIVK Comparison

RFL vs VIVK Comparison

Compare RFL & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • VIVK
  • Stock Information
  • Founded
  • RFL 2017
  • VIVK 2006
  • Country
  • RFL United States
  • VIVK United States
  • Employees
  • RFL N/A
  • VIVK N/A
  • Industry
  • RFL Real Estate
  • VIVK Oilfield Services/Equipment
  • Sector
  • RFL Finance
  • VIVK Energy
  • Exchange
  • RFL Nasdaq
  • VIVK Nasdaq
  • Market Cap
  • RFL 55.3M
  • VIVK 43.8M
  • IPO Year
  • RFL N/A
  • VIVK N/A
  • Fundamental
  • Price
  • RFL $1.92
  • VIVK $1.22
  • Analyst Decision
  • RFL
  • VIVK
  • Analyst Count
  • RFL 0
  • VIVK 0
  • Target Price
  • RFL N/A
  • VIVK N/A
  • AVG Volume (30 Days)
  • RFL 27.8K
  • VIVK 21.7K
  • Earning Date
  • RFL 12-27-2024
  • VIVK 11-19-2024
  • Dividend Yield
  • RFL N/A
  • VIVK N/A
  • EPS Growth
  • RFL N/A
  • VIVK N/A
  • EPS
  • RFL N/A
  • VIVK N/A
  • Revenue
  • RFL $697,000.00
  • VIVK $61,991,772.00
  • Revenue This Year
  • RFL N/A
  • VIVK N/A
  • Revenue Next Year
  • RFL N/A
  • VIVK N/A
  • P/E Ratio
  • RFL N/A
  • VIVK N/A
  • Revenue Growth
  • RFL 151.62
  • VIVK 0.33
  • 52 Week Low
  • RFL $1.29
  • VIVK $0.67
  • 52 Week High
  • RFL $2.50
  • VIVK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.58
  • VIVK 38.11
  • Support Level
  • RFL $1.71
  • VIVK $1.15
  • Resistance Level
  • RFL $1.92
  • VIVK $1.50
  • Average True Range (ATR)
  • RFL 0.10
  • VIVK 0.14
  • MACD
  • RFL -0.00
  • VIVK -0.03
  • Stochastic Oscillator
  • RFL 84.00
  • VIVK 32.65

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.

Share on Social Networks: